Genes can determine chemotherapy program for colorectal cancer patients
Testing the tumors of advanced colorectal cancer patients can determine whether patients who have already failed a round or more of chemotherapy would benefit from further chemotherapy, according to a study by USC/Norris Comprehensive Cancer Center oncologists presented this weekend at the American Society of Clinical Oncology annual meeting. Contact: Jon Weiner jonweine@hsc.usc.edu 323-442-2830 University of Southern California
Message posted by: Wouter Kalle
|